Discovering breakthroughs in fibrosis and neurodegeneration

Blade Clinical Trials

Today, we are advancing a differentiated pipeline of oral, small-molecule therapies that include a non-competitive autotaxin inhibitor and inhibitors of dimeric calpains for the potential treatment of lung, liver and cardiac fibrosis or neurodegenerative diseases.

Find Clinical Trials Near Me

Study Description Study Phase Status Trial number
BLD-0409-101 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Phase 1 Complete NCT04146805
BLD-0409-102 Relative Bioavailability Phase 1 Complete NCT04814472
BLD-0409-103 Drug-Drug Interaction with Probe Substrates for CYP450 Enzymes Phase 1 Complete NCT04814498
BLD-0409-104 Drug-Drug Interaction with Approved Therapies for IPF Phase 1 Complete NCT04939467
BLD-0409-201 Idiopathic Pulmonary Fibrosis Phase 2 Planned NCT05373914